Amneal Expects Host Of New Launches To Drive Firm To Success

US Firm Is One Of Few Generics Players Growing In Difficult Market

Despite a couple of setbacks during Q2, Amneal has sustained continual growth across its business, particularly in the injectables space.

Single green shoot in dry land
Amneal is one of the few generics firms growing in a difficult market • Source: Shutterstock

More from Earnings

More from Business